SCHEMBL30786153

SCHEMBL30786153

O=C(NC1CC1)c1cccc(F)c1Sc1ccc2c(/C=C/c3ccc(CN4CCCC4)cn3)nn(C3CCCCO3)c2c1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.36
CCR3 P51677 1/20 0.35
PDE4B Q07343 1/20 0.34
ACKR3 P25106 3/20 0.33
MCHR1 Q99705 3/20 0.33
KDM4E B2RXH2 1/20 0.33
DRD4 P21917 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SMO Q99835 1/20 0.32
DRD3 P35462 1/20 0.32
SSTR5 P35346 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30786152 0.90 KDR (0.35) KDR
SCHEMBL30786061 0.89 KDR (0.38) KDRCCR3PDE4BMCHR1KDM4E
SCHEMBL30786078 0.87 KDR (0.36) KDRMCHR1DRD4
SCHEMBL30786156 0.87 KDR (0.35) KDRCCR3DRD4KMT2A
SCHEMBL30786135 0.86 KDR (0.35) KDRDRD4KMT2A
SCHEMBL31475188 0.84 AXL (0.41) KDRMCHR1KDM4EDRD4NPC1
SCHEMBL30786086 0.83 KDR (0.32) KDR
SCHEMBL30786196 0.83 KDR (0.43) KDRKMT2A
SCHEMBL30786075 0.83 KDR (0.49) KDRACKR3DRD4
SCHEMBL30786218 0.82 KDR (0.31) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082316-A1 OPHTHALMIC FORMATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州必扬医药科技有限公司 2025-04-24 WO disclosed
CN-119604488-A Protein tyrosine kinase inhibitor and medical application thereof 苏州必扬医药科技有限公司 2025-03-11 CN disclosed
WO-2024032584-A1 PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF 苏州必扬医药科技有限公司 2024-02-15 WO disclosed